Publications


Commitment to science

Our commitment to science is reflected in our track record of publications. Here are a few recent examples of high impact publications co-authored by AstraZeneca and/or MedImmune scientists.


Respiratory

Published:

Immunity. Published online 21 November 2017 http://dx.doi.org/10.1016/j.immuni.2017.10.017

Author(s):


Early Discovery

Published:

Nature Communications 8. Published online 20th November 2017 doi:10.1038/s41467-017-01732-9

Author(s):


CVMD

Published:

Nature Medicine Published online: 13 November 2017 doi:10.1038/nm.4437

Author(s):


Oncology

Published:

Nature Protocols 12, 2465–2477 (2017) Published online 02 November 2017 doi:10.1038/nprot.2017.118

Author(s):


CVMD

Published:

The British Medical Journal, 2017;359, doi: 10.1136/bmj.j4511

Author(s):


CVMD

Published:

Cell, 171, 1–12, November 2, 2017, doi.10.1016/j.cell.2017.09.045

Author(s):


Oncology

Published:

The Lancet Respiratory Medicine, published online October 19 2017, doi.10.1016/ S2213-2600(17)30378-8

Author(s):


Oncology

Published:

Cell, published online ahead of print 19 October 2017, doi: 10.1016/j.molcel.2017.09.024

Author(s):


Early Discovery

Published:

Nature Methods, published online ahead of print 16 October 2017, doi:10.1038/nmeth.4466

Author(s):


Early Discovery

Published:

Nature Reviews Drug Discovery, published online ahead of print, doi:10.1038/nrd.2017.177

Author(s):


Oncology

Published:

Journal of Clinical Oncology, published online ahead of print 2 October 2017, doi: 10.1200/JCO.2017.73.9250

Author(s):


Early Discovery

Published:

Nature Reviews Drug Discovery, published online ahead of print 22 September 2017, doi:10.1038/nrd.2017.146

Author(s):


Early Discovery

Published:

Nature, published online ahead of print 20 September 2017, doi:10.1038/nature24016

Author(s):


Oncology

Published:

Journal of Clinical Oncology, published online ahead of print 25 August 2017, doi: 10.1200/JCO.2017.74.7576

Author(s):


CVMD

Published:

Cell Research. 2017; 27: 1157-1177. doi:10.1038/cr.2017.103

Author(s):


CVMD

Published:

JAMA. 2017;318(7):637-646. doi:10.1001/jama.2017.10169

Author(s):


CVMD

Published:

Nature Communications, published online ahead of print 20 July 2017, doi:10.1038/s41467-017-00118-1

Author(s):


Oncology

Please read the related article 'Finding a cancer ‘off switch’ for mutant Ras' by clicking on the link below.

Published:

Nature Communications, published online ahead of print 14 July 2017, DOI: 10.1038/ncomms16111

Author(s):


Early discovery

Published:

Nature Biotechnology, published online ahead of print 30 June 2017, doi:10.1038/nmicrobiol.2017.104

Author(s):


Respiratory

Published:

The Lancet Respiratory Medicine, published online ahead of print 28 June 2017, DOI: 10.1016/S2213-2600(17)30207-2

Author(s):


Early discovery

Published:

Nature Communications, published online 26 June 2017, doi:10.1038/ncomms15475

Author(s):


Oncology

Published:

Journal of Clinical Oncology, published online ahead of print 23 June 2017, DOI: 10.1200/JCO.2017.72.2967

Author(s):


Oncology

Please read the related article 'Switching the light off in the discovery of new cancer therapies against KRAS' by clicking on the link below.

Published:

Science Translational Medicine, published 14 June 2017, DOI: 10.1126/scitranslmed.aal5253

Author(s):


Respiratory

Please read the related article 'CompEx: novel exacerbation measure may speed up asthma drug development' by clicking on the link below.

Published:

The Lancet Respiratory Medicine, published online ahead of print1 June 2017, DOI:http://dx.doi.org/10.1016/S2213-2600(17)30218-7

Author(s):


Early discovery

Published:

Clinical Microbiology Reviews, published online ahead of print 11 May 2017, DOI: 10.1128/CMR.00111

Author(s):


Early discovery

Please read the related article 'Revealing the dynamic structure of ATM' by clicking on the link below.

Published:

Science Advances 10 May 2017: Vol. 3, no. 5, e1700933 DOI: 10.1126/sciadv.1700933

Author(s):


Oncology

Published:

Journal of Clinical Oncology - published online ahead of print May 10, 2017 DOI: 10.1200/JCO.2017.73.0143

Author(s):


Early discovery

Please read the related article 'New structural insight into the highly challenging drug target PAR2 helps paves the way for future therapies in inflammatory pain' by clicking on the link below.

Published:

Nature, published online 26 April 2017 DOI: 10.1038/nature22309

Author(s):


Early Clinical Development

Published:

The Lancet, published online 3 April 2017 DOI: http://dx.doi.org/10.1016/S0140-6736(17)30823-1

Author(s):


CVMD

Please read the related article 'Early intervention for pre-diabetes shown to prevent long-term complications' by clicking on the link below.

Published:

The Lancet (2017) Published online 22 February 2017 doi:10.1016/S2213-8587(17)30061-X

Author(s):


Respiratory

Published:

Nature Genetics (2017) Published online 06 February 2017 doi:10.1038/ng.3752

Author(s):


Early discovery

Published:

Nature Chemical Biology (2017) Published online 09 January 2017 DOI:10.1038/nchembio.2270

Author(s):


Oncology

Please read the related article 'New directions for ER+ breast cancer treatment: do estrogen receptor gene mutations hold the key?' by clicking on the link below.

Published:

Cancer Discovery Published 16 December 2016 DOI: 10.1158/2159-8290.CD-15-1523

Author(s):


Oncology

Published:

Nature Chemistry 12 Dec 2016 DOI:10.1038/nchem.2670

Author(s):


Discovery Sciences

Published:

Nature Reviews Drug Discovery Published online: 09 December 2016 DOI:10.1038/nrd.2016.213

Author(s):


Oncology

Please read the related article 'Novel pre-clinical brain metastases models show good translation to clinical setting' by clicking on the link below.

Published:

Science Translational Medicine 07 Dec 2016: Vol. 8, Issue 368, pp. 368ra172 Published online: 7 December 2016 DOI:10.1126/scitranslmed.aag0976

Author(s):


CVMD

Published:

Nature Biomedical Engineering 1, Article number: 0003 (2016) Published online: 5 December 2016 DOI:10.1038/s41551-016-0003

Author(s):


Oncology

Published:

Nature Medicine (2016) Published online: 21 November 2016 DOI: 10.1038/nm.4239

Author(s):


CVMD

Published:

Chem. Rev., Article, Published online: 18 November 2016 DOI: 10.1021/acs.chemrev.6b00466

Author(s):


CVMD

Please read the related article 'A new role for IGF1 signalling in driving fat tissue formation in heart disease' by clicking on the link below.

Published:

Circulation. 2016;CIRCULATIONAHA.116.022064 DOI: http://dx.doi.org/10.1161/CIRCULATIONAHA.116.022064

Author(s):


CVMD

Published:

Circulation. 2016;CIRCULATIONAHA.116.024014 DOI: http://dx.doi.org/10.1161/CIRCULATIONAHA.116.024014

Author(s):


Oncology

Published:

Science Translational Medicine 26 Oct 2016: Vol. 8, Issue 362, pp. 362ps17 DOI: 10.1126/scitranslmed.aaf9246

Author(s):


Oncology

Published:

Nature Medicine 22, 1303–1313 (2016), published online 24 October 2016 DOI:10.1038/nm.4198

Author(s):


Oncology

Published:

Nature Chemical Biology (2016) Published online 24 October 2016, doi:10.1038/nchembio.2210

Author(s):


CVMD

Published:

Nature Chemical Biology (2016), published online 17 October 2016 doi:10.1038/nchembio.2203

Author(s):


Oncology

Published:

Nature Reviews Clinical Oncology DOI:10.1038/nrclinonc.2016.162 Published online 11 Oct 2016

Author(s):


CVMD

Published:

Nature Communications 7, Article number: 12962 (2016) doi:10.1038/ncomms12962

Author(s):


Respiratory

Published:

The Lancet, Volume 4, No. 10, p797–806, October 2016 DOI: http://dx.doi.org/10.1016/S2213-2600(16)30227-2

Author(s):


Early Clinical Development

Published:

Nature 538, 248–252 (13 October 2016) doi:10.1038/nature19806

Author(s):


Oncology

Published:

Cell Discovery 2, Article number: 16031 (2016) doi:10.1038/celldisc.2016.31

Author(s):


CVMD

Please read the related article 'Innovative pancreatic research expands treatment horizons for people with type 2 diabetes' by clicking on the link below.

Published:

Cell Metabolism (2016) http://dx.doi.org/10.1016/j.cmet.2016.08.020

Author(s):


Oncology

Published:

Cell, Volume 167, Issue 1, p260–274.e22, 22 September 2016 DOI: http://dx.doi.org/10.1016/j.cell.2016.08.041

Author(s):



Oncology

Published:

Nature Reviews Materials 1, Article number: 16069 (2016) doi:10.1038/natrevmats.2016.69

Author(s):


Oncology

Please read the related article 'Opening up a treasure trove of new drug target opportunities' by clicking on the link below.

Published:

Nature Chemical Biology (2016) Published online 05 September 2016 doi:10.1038/nchembio.2174

Author(s):


Respiratory

Published:

The Lancet Respiratory Medicine DOI: 10.1016/S2213-2600(16)30227-2

Author(s):


Cardiovascular and Metabolic diseases

Please read the related article 'Breakthrough research revealing novel drivers of cardiometabolic diseases published in Science' by clicking on the link below.

Published:

Science 19 Aug 2016: Vol. 353, Issue 6301, pp. 827-830 DOI: 10.1126/science.aad6970

Author(s):


Oncology

Please read the related article 'Uncovering world’s first structural clues to inhibiting an emerging DNA Damage Response target area for future anti-cancer therapy' by clicking on the link below.

Published:

Nature Chemical Biology; 15 August 2016, doi: 10.1038/nchembio.2148

Author(s):


Oncology

Published:

Journal of Clinical Oncology DOI: 10.1200/JCO.2016.66.7162 Journal of Clinical Oncology 34, no. 28 (October 2016) 3375-3382.

Author(s):


Oncology

Published:

The New England Journal of Medicine DOI: 10.1056/NEJMoa1505971

Author(s):


Oncology

Please read the related article 'New study published in ‘Cancer Cell’ furthers understanding role of CXCR2 in pancreatic cancer' by clicking on the link below.

Published:

Cancer Cell, Volume 29, Issue 6, p832–845, 13 June 2016

Author(s):


Oncology

Published:

Nature 534, 272–276 (09 June 2016) doi:10.1038/nature17963

Author(s):


Oncology

Published:

Published online 01 June 2016; Nature Reviews Clinical Oncology (2016) doi:10.1038/nrclinonc.2016.79

Author(s):


Medicinal chemistry

Published:

Advanced Drug Delivery Reviews; Volume 101, 1 June 2016, Pages 42–61. http://dx.doi.org/10.1016/j.addr.2016.03.013

Author(s):


Oncology

Published:

Nature 534, 272–276 (09 June 2016) Published online 18 May 2016 DOI:10.1038/nature17963

Author(s):


Oncology

Published:

Advanced Drug Delivery Reviews DOI:10.1016/j.addr.2016.04.025

Author(s):


Oncology

Published:

Nature Medicine DOI: 10.1158/2159-8290.CD-15-1246 Published 13 May 2016

Author(s):


Personalised healthcare

Published:

Nature Reviews Drug Discovery 15, 369–370 (2016); Published Online May 13, 2016; DOI:10.1038/nrd.2016.74

Author(s):


Oncology

Please read the related article 'Clinical trial data unveil a driver of FGFR inhibitor response in gastric cancer' by clicking on the link below.

Published:

Published Online May 13, 2016; doi: 10.1158/2159-8290.CD-15-1246

Author(s):


Respiratory

Published:

12 May 2016 N Engl J Med 2016; 374:1811-1821DOI: 10.1056/NEJMoa1505971

Author(s):


Neuroscience

Please read the related article 'AstraZeneca and Lieber Institute for Brain Development publish discovery of novel protein associated with schizophrenia' by clicking on the link below.

Published:

Published online 9 May 2016; Nature Medicine 22, 649–656 (2016) doi:10.1038/nm.4096

Author(s):


Oncology

Published:

Published online 5 May 2016; Nature Medicine 22, 464–471 (2016) doi:10.1038/nm.4089

Author(s):


Oncology

Please read the related article 'Defining a new approach to developing nanomedicines for cancer therapies' by clicking on the link below.

Published:

Published Online April, 2016; Advanced Drug Delivery Reviews http://dx.doi.org/10.1016/j.addr.2016.04.025

Author(s):


Oncology

Please read the related article 'New genomic classification approach strengthens early cancer trial design' by clicking on the link below.

Published:

Published online 26 April 2016; Nature Reviews Cancer 16, 319–329 (2016) doi:10.1038/nrc.2016.35

Author(s):


CVMD

Published:

Advanced Drug Delivery Reviews DOI: 10.1016/j.addr.2016.03.013

Author(s):


Oncology

Published:

Immunity: Volume 44, Issue 3, 15 March 2016, Pages 698–711 DOI: http://dx.doi.org/10.1016/j.immuni.2016.02.025

Author(s):


Oncology

Published:

Science Translational Medicine 24 Feb 2016: Vol. 8, Issue 327, pp. 327ra26 DOI: 10.1126/scitranslmed.aad6352

Author(s):


Oncology

Please read the related article 'AstraZeneca and BIND Therapeutics publish AZD2811 ACCURINS® data in Science Translational Medicine' by clicking on the link below.

Published:

Science Translational Medicine 10 Feb 2016: Vol. 8, Issue 325, pp. 325ra17 DOI: 10.1126/scitranslmed.aad2355

Author(s):